Buchi Kevin J.'s Insider Trades & SAST Disclosures
Buchi Kevin J.'s most recent trade in Amneal Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 40,258 Restricted Stock Units done . Disclosure was reported to the exchange on May 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Buchi Kevin J..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharmaceuticals Inc... | J. Kevin Buchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 40,258 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | J. Kevin Buchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 40,258 | 40,258 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | J. Kevin Buchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 34,819 | 34,819 | - | - | Restricted Stock Units | |
| Benitec Biopharma Inc | J. Kevin Buchi | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Mar 2025 | 103,626 | 284 | - | 0 | Common Stock | |
| Benitec Biopharma Inc | J. Kevin Buchi | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Mar 2025 | 103,626 | 103,626 | - | 0 | Common Stock | |
| Amneal Pharmaceuticals Inc... | J. Kevin Buchi | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Mar 2025 | 262,072 | 0 (0%) | 0% | 0 | Class A Common Stock | |
| Benitec Biopharma Inc | J. Kevin Buchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.86 per share. | 27 Feb 2025 | 51,813 | 103,910 | - | 3.9 | 199,998 | Common Stock |
| Benitec Biopharma Inc | J. Kevin Buchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 51,813 | 0 | - | - | Common Warrants (right to buy) | |
| Benitec Biopharma Inc | J. Kevin Buchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 35,000 | 35,000 | - | - | Options (right to buy) | |
| Amneal Pharmaceuticals Inc... | J. Kevin Buchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 76,453 | 262,072 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | J. Kevin Buchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 76,453 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | J. Kevin Buchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 40,258 | 40,258 | - | - | Restricted Stock Units | |
| Benitec Biopharma Inc | Buchi Kevin J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2023 | 35,000 | 35,000 | - | - | Options (right to buy) | |
| Benitec Biopharma Inc | J. Kevin Buchi | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Aug 2023 | 51,813 | 52,097 | - | - | Common Stock | |
| Benitec Biopharma Inc | J. Kevin Buchi | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Aug 2023 | 51,813 | 51,813 | - | - | Common Warrants (right to buy) | |
| Amneal Pharmaceuticals Inc... | J. Kevin Buchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 80,128 | 185,619 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | J. Kevin Buchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 80,128 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | J. Kevin Buchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 76,453 | 76,453 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | J. Kevin Buchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2022 | 80,128 | 80,128 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | J. Kevin Buchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2022 | 35,406 | 105,491 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | J. Kevin Buchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2022 | 35,406 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | J. Kevin Buchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 46,218 | 70,085 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | J. Kevin Buchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 46,218 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | J. Kevin Buchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2021 | 35,406 | 35,406 | - | - | Restricted Stock Units | |
| Alaunos Therapeutics Inc | J. Kevin Buchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 31,250 | 31,250 | - | - | Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | J. Kevin Buchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 4,167 | 4,167 (0%) | 0% | 0 | Common Stock | |
| Benitec Biopharma Inc | J. Kevin Buchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2020 | 23,601 | 23,601 | - | - | Options (right to buy) | |
| Alaunos Therapeutics Inc | J. Kevin Buchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2020 | 146,190 | 146,190 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges